First-Turn-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
35
Total Value
496050761
Accession Number
0001085146-25-003195
Form Type
13F-HR
Manager Name
First-Turn-Management
Data Enrichment
100% identified
35 identified0 unidentified

Holdings

35 positions • $496.1M total value
Manager:
Search and click to pin securities to the top
Page 2 of 2
Janux Therapeutics, Inc.
Shares:430.2K
Value:$11.6M
% of Portfolio:2.3% ($11.6M/$496.1M)
Oric Pharmaceuticals, Inc.
Shares:2.0M
Value:$11.3M
% of Portfolio:2.3% ($11.3M/$496.1M)
ADMA BIOLOGICS, INC.
Shares:566.9K
Value:$11.2M
% of Portfolio:2.3% ($11.2M/$496.1M)
INTUITIVE SURGICAL INC
Shares:22.1K
Value:$10.9M
% of Portfolio:2.2% ($10.9M/$496.1M)
Enliven Therapeutics, Inc.
Shares:535.1K
Value:$10.5M
% of Portfolio:2.1% ($10.5M/$496.1M)
Vaxcyte, Inc.
Shares:276.9K
Value:$10.5M
% of Portfolio:2.1% ($10.5M/$496.1M)
Apogee Therapeutics, Inc.
Shares:229.7K
Value:$8.6M
% of Portfolio:1.7% ($8.6M/$496.1M)
ARS Pharmaceuticals, Inc.
Shares:669.0K
Value:$8.4M
% of Portfolio:1.7% ($8.4M/$496.1M)
Blueprint Medicines Corp
Shares:92.0K
Value:$8.1M
% of Portfolio:1.6% ($8.1M/$496.1M)
RadNet, Inc.
Shares:157.6K
Value:$7.8M
% of Portfolio:1.6% ($7.8M/$496.1M)
HEALTHEQUITY, INC.
Shares:84.0K
Value:$7.4M
% of Portfolio:1.5% ($7.4M/$496.1M)
MoonLake Immunotherapeutics
Shares:179.2K
Value:$7.0M
% of Portfolio:1.4% ($7.0M/$496.1M)
HARROW, INC.
Shares:188.8K
Value:$5.0M
% of Portfolio:1.0% ($5.0M/$496.1M)
Praxis Precision Medicines, Inc.
Shares:71.8K
Value:$2.7M
% of Portfolio:0.5% ($2.7M/$496.1M)
SOLENO THERAPEUTICS INC
Shares:29.1K
Value:$2.1M
% of Portfolio:0.4% ($2.1M/$496.1M)